Agreements, Financial Results, Upcoming Conference Calls, Analysis Results, and Technical Updates - Research Reports on SunEdison, Avago, LinkedIn, Equinix and athenahealth

NEW YORK, October 22, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding SunEdison, Inc. (NYSE: SUNE), Avago Technologies Limited (NASDAQ: AVGO), LinkedIn Corporation (NYSE: LNKD), Equinix, Inc. (NASDAQ: EQIX) and athenahealth, Inc. (NASDAQ: ATHN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7364-100free.

--
SunEdison, Inc. Research Reports
On October 16, 2014, SunEdison, Inc. (SunEdison) announced a joint venture agreement with JIC Capital to facilitate nonrecourse financing and to develop, construct and own up to 1 Gigawatt (GW) of utility-scale solar photovoltaic (PV) projects in China- one of the world's largest and most attractive solar markets - over the next 3 years. SunEdison informed that the Company, directly or through an affiliate, including a yieldco, may purchase the projects developed by the joint venture at fair market value. Ahmad Chatila, President and CEO of SunEdison said, "This historic joint venture is a great step forward for SunEdison. It is a great honor to partner with a leader like JIC Capital, and we are committed to harnessing our world leading technology and deployment capabilities to deliver clean, cost effective solar energy to the people of China." The full research reports on SunEdison are available to download free of charge at:

http://www.analystsreview.com/Oct-22-2014/SUNE/report.pdf

--
Avago Technologies Limited Research Reports
On October 17, 2014, Avago Technologies Limited's (Avago) stock closed higher for the fourth straight session, gaining 2.05% to close the session at $77.15. Avago' stock fluctuated between $76.83 and $79.70 during the trading session. The stock has a 52-week range of $42.45- $90.88. Shares in Avago have surged 26.70% over the last six months, as compared to Nasdaq Composite that gained 3.98% over the same period of time. The stock closed above its 200-day moving average of $68.41, which was below the stock's 50-day moving average of $80.98. The full research reports on Avago are available to download free of charge at:

http://www.analystsreview.com/Oct-22-2014/AVGO/report.pdf

--
LinkedIn Corporation Research Reports
In a blog post dated October 16, 2014 by Mathieu Bastian Senior Data Scientist, Team Lead at LinkedIn Corporation (LinkedIn), published on the Company website, he stated that members who list skills on their LinkedIn profiles receive an average of 13 times more profile views than those who don't. Bastian said that analysis by LinkedIn unveiled a surprising trend: non-IT skills are on the rise on LinkedIn as skills related to health care, administration, hospitality, retail, and education are seeing the most significant growth. As per the blog, Health Care is a top growing industry in France, Canada, and Italy; Construction and Architecture are on the rise in Argentina, Brazil, Mexico, Russia, and Turkey; and Retail and Manufacturing are the front-runners in China. The full research reports on LinkedIn are available to download free of charge at:

http://www.analystsreview.com/Oct-22-2014/LNKD/report.pdf

--
Equinix, Inc. Research Reports
On October 14, 2014, Equinix, Inc. (Equinix) announced that it will hold its quarterly conference call to discuss its Q3 2014 financial results on Wednesday, October 29, 2014 at 5:30 p.m. ET (2:30 p.m. PT). Equinix informed that a live webcast of the call will be available at its website under the Investor Relations. According to Zacks Investment Research, the EPS consensus estimate for the quarter is $0.88. The full research reports on Equinix are available to download free of charge at:

http://www.analystsreview.com/Oct-22-2014/EQIX/report.pdf

--
athenahealth, Inc. Research Reports
On October 16, 2014, athenahealth, Inc. (athenahealth) announced its Q3 2014 financial results with total revenue of $190.4 million, up 25.7% YoY, in line with 22 Wall Street analysts' consensus estimate. The Company's non-GAAP adjusted net income was $10.4 million or $0.27 per diluted shares versus $11.2 million or $0.29 per diluted share in Q3 2013. On average, 26 analysts polled by Thomson Reuters expected earnings (excluding special items) of $0.27 per share. Kristi Matus, Chief Financial and Administrative Officer of athenahealth said, "The athenahealth team continued to make marked progress against our financial and operational goals in the third quarter and we are strongly positioned to continue to drive meaningful change in health care." For full-year 2014, the Company expects total revenue to be at or above the mid-point of its guidance of $725 million to $755 million. Non-GAAP adjusted net income per diluted share is anticipated to be close to the high end of the $0.98 to $1.10 guidance range. The Company's stock moved down 1.42% on the day of the announcement. The full research reports on athenahealth are available to download free of charge at:

http://www.analystsreview.com/Oct-22-2014/ATHN/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED